Torrent Pharma board okays hiking borrowing limit to Rs 15,000 crore
Torrent Pharmaceuticals said its Board has approved a proposal to enhance borrowing limits from Rs 10,000 crore to Rs 15,000 crore.
As per a BSE filing, the Board also approved "issuance of unsecured/secured redeemable non-convertible debentures/bonds by way of private placement for an amount not exceeding Rs 12,500 crore".
The Board also cleared a proposal for issuance of equity shares including convertible bonds/debentures through qualified institutional placement (QIP) and or depository receipts or any other modes for an amount not exceeding Rs 5,000 crore, the company said in the filing.
The drug firm, however, did not mention what it intends to do with the proposed fundraising.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd